Walter Mier
Impact in
- Radiology, Nuclear Medicine and Imaging top 0.05%
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
- Oncology top 0.2%
- Peptidase Inhibition and Analysis
Papers in
-
- Radiopharmaceutical Chemistry and Applications 67
- Monoclonal and Polyclonal Antibodies Research 32
- Medical Imaging Techniques and Applications 21
-
- RNA Interference and Gene Delivery 19
- Chemical Synthesis and Analysis 19
- Co-authors
- Uwe Haberkorn (151 shared papers)Clemens Kratochwil (47 shared papers)Frederik L. Giesel (38 shared papers)Jürgen Debus (24 shared papers)Annette Altmann (44 shared papers)Michael Eisenhut (46 shared papers)Klaus Kopka (29 shared papers)Thomas Lindner (24 shared papers)
- Journals
- Journal of Nuclear Medicine (24 papers)European Journal of Nuclear Medicine and Molecular Imaging (20 papers)Bioconjugate Chemistry (9 papers)Molecules (7 papers)Nuclear Medicine and Biology (7 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Walter Mier
240 papers receiving 15.3k citations
Walter Mier's Hit Papers
Peers
Comparison fields: 5 of 153
- Radiology, Nuclear Medicine and Imaging 5.5k
- Oncology 5.5k
- Pulmonary and Respiratory Medicine 4.3k
- Cancer Research 1.8k
- Hepatology 548
Countries citing papers authored by Walter Mier
This map shows the geographic impact of Walter Mier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Walter Mier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Walter Mier more than expected).
Fields of papers citing papers by Walter Mier
This network shows the impact of papers produced by Walter Mier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Walter Mier. The network helps show where Walter Mier may publish in the future.
Co-authors
The 25 scholars most cited alongside Walter Mier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 244 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 68Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer Hit paper breakdown → | 2019 | 1005 |
| 2 | 68Ga-Complex Lipophilicity and the Targeting Property of a Urea-Based PSMA Inhibitor for PET Imaging Hit paper breakdown → | 2012 | 696 |
| 3 | Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation Protein Hit paper breakdown → | 2018 | 685 |
| 4 | The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis Hit paper breakdown → | 2005 | 563 |
| 5 | A Tumor-Imaging Method Targeting Cancer-Associated Fibroblasts Hit paper breakdown → | 2018 | 558 |
| 6 | 68Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers Hit paper breakdown → | 2018 | 517 |
| 7 | Preclinical Evaluation of a Tailor-Made DOTA-Conjugated PSMA Inhibitor with Optimized Linker Moiety for Imaging and Endoradiotherapy of Prostate Cancer Hit paper breakdown → | 2015 | 475 |
| 8 | PSMA-Targeted Radionuclide Therapy of Metastatic Castration-Resistant Prostate Cancer with 177Lu-Labeled PSMA-617 Hit paper breakdown → | 2016 | 471 |
| 9 | F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients Hit paper breakdown → | 2016 | 451 |
| 10 | Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients Hit paper breakdown → | 2017 | 405 |
| 11 | Development of Fibroblast Activation Protein–Targeted Radiotracers with Improved Tumor Retention Hit paper breakdown → | 2019 | 391 |
| 12 | The Theranostic PSMA Ligand PSMA-617 in the Diagnosis of Prostate Cancer by PET/CT: Biodistribution in Humans, Radiation Dosimetry, and First Evaluation of Tumor Lesions Hit paper breakdown → | 2015 | 343 |
| 13 | 2014 | 321 | |
| 14 | Betulinic acid triggers CD95 (APO-1/Fas)- and p53-independent apoptosis via activation of caspases in neuroectodermal tumors. | 1997 | 311 |
| 15 | Radiation dosimetry and first therapy results with a 124I/131I-labeled small molecule (MIP-1095) targeting PSMA for prostate cancer therapy Hit paper breakdown → | 2014 | 282 |
| 16 | 2013 | 197 | |
| 17 | 2009 | 196 | |
| 18 | 2016 | 183 | |
| 19 | 2017 | 168 | |
| 20 | 2010 | 168 |
About Walter Mier
Walter Mier is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology, Oncology, Pulmonary and Respiratory Medicine and Epidemiology, having authored 244 papers that have together received 15.5k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (67 papers), Prostate Cancer Treatment and Research (34 papers), Monoclonal and Polyclonal Antibodies Research (32 papers), Peptidase Inhibition and Analysis (30 papers), Medical Imaging Techniques and Applications (21 papers), RNA Interference and Gene Delivery (19 papers), Chemical Synthesis and Analysis (19 papers) and Antimicrobial Peptides and Activities (18 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (5.5k citations), Oncology (5.5k citations), Pulmonary and Respiratory Medicine (4.3k citations), Cancer Research (1.8k citations) and Hepatology (548 citations). Walter Mier has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Uwe Haberkorn, Clemens Kratochwil, Frederik L. Giesel, Jürgen Debus, Annette Altmann, Michael Eisenhut, Klaus Kopka, Thomas Lindner, Matthias Eder and Martin Schäfer. Their work appears in journals such as Journal of Nuclear Medicine, European Journal of Nuclear Medicine and Molecular Imaging, Bioconjugate Chemistry, Molecules and Nuclear Medicine and Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.